DiviDrip · IRD

IRD — Opus Genetics, Inc.

IRD is Opus Genetics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $4.67. Market cap: $389M. Capital Quality Rank: 10/100 — Systemic risk.

Stock snapshot

Price$4.67
Market cap$389M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)10 / 100 · Systemic risk
Shareholder buyback yield-30.00%
Altman Z-score zoneDistress

About IRD

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes seven adeno-associated virus (AAV)-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, CNGB1, RDH12, NMNAT1, and MERTK. The company operates in one operating segment, which is the business of developing products related to vision performance and health.

Listed2020Employees28HQDurham, NCSectorHealthcareWebsiteopusgtx.com

Related non-dividend companies

Other non-dividend stocks investors research alongside IRD. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is IRD's current stock price?

IRD (Opus Genetics, Inc.) is currently trading at $4.67.

Does IRD pay a dividend?

IRD (Opus Genetics, Inc.) does not currently pay a regular dividend.

What is IRD's Capital Quality Rank?

IRD has a Capital Quality Rank of 10/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track IRD in DiviDrip

Add IRD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow